The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vassiliadou, N.
Right arrow Articles by Anderson, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vassiliadou, N.
Right arrow Articles by Anderson, D. J.
The Journal of Immunology, 1999, 162: 7510-7518.
Copyright © 1999 by The American Association of Immunologists

Progesterone-Induced Inhibition of Chemokine Receptor Expression on Peripheral Blood Mononuclear Cells Correlates with Reduced HIV-1 Infectability In Vitro1

Neratzoula Vassiliadou, Lynne Tucker and Deborah J. Anderson2

Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115

Recent studies have shown that progesterone, a sex steroid hormone, enhances the sexual transmission of various pathogens, including SIV. The goal of this study was to determine whether progesterone affects mechanisms underlying the sexual transmission of HIV-1. We first studied the effects of various physiologic concentrations of progesterone on the expression of chemokines and chemokine receptors by T cells and macrophages. Chemokines are involved in leukocyte recruitment to peripheral sites; in addition, the chemokine receptors CCR5 and CXCR4 are HIV-1 coreceptors, and their ligands can block HIV-1 infection. Progesterone treatment had no effect on constitutive expression of CCR5 and CXCR4 by nonactivated T cells and macrophages, but significantly inhibited IL-2-induced up-regulation of CCR5 and CXCR4 on activated T cells (p < 0.05). Progesterone also inhibited both mitogen-induced proliferation and chemokine secretion (macrophage inflammatory protein-1{alpha}, macrophage inflammatory protein-1ß, RANTES) by CD8+ T lymphocytes. Control and progesterone-treated PBMC cultures were also tested for susceptibility to infection by T cell-tropic (HIV-1MN) and macrophage-tropic (HIV-1JR-CSF) viral strains in vitro. Infection with low titers of HIV-1MN was consistently inhibited in progesterone-treated cultures; progesterone effects on infection with the HIV-1JR-CSF strain were more variable, but correlated with progesterone-induced reductions in CCR5 levels. These results indicate that progesterone treatment can inhibit mechanisms underlying HIV-1 transmission, including infection of CD4+ target cells via CXCR4/CCR5 coreceptors and effects on chemokine-mediated recruitment of lymphocytes and monocytes to mucosal epithelia.




This article has been cited by other articles:


Home page
 Reproductive SciencesHome page
J. S. Sheffield, G. D. Wendel Jr, D. D. McIntire, and M. V. Norgard
The Effect of Progesterone Levels and Pregnancy on HIV-1 Coreceptor Expression
Reproductive Sciences, January 1, 2009; 16(1): 20 - 31.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M.-P. Belot, L. Abdennebi-Najar, F. Gaudin, M. Lieberherr, V. Godot, J. Taieb, D. Emilie, and V. Machelon
Progesterone reduces the migration of mast cells toward the chemokine stromal cell-derived factor-1/CXCL12 with an accompanying decrease in CXCR4 receptors
Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1410 - E1417.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
W. M. Mlynarski, G. P. Placha, P. P. Wolkow, J. P. Bochenski, J. H. Warram, and A. S. Krolewski
Risk of Diabetic Nephropathy in Type 1 Diabetes Is Associated With Functional Polymorphisms in RANTES Receptor Gene (CCR5): A Sex-Specific Effect
Diabetes, November 1, 2005; 54(11): 3331 - 3335.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
T. E. Taha, S. Nour, N. I. Kumwenda, R. L. Broadhead, S. A. Fiscus, G. Kafulafula, C. Nkhoma, S. Chen, and D. R. Hoover
Gender Differences in Perinatal HIV Acquisition Among African Infants
Pediatrics, February 1, 2005; 115(2): e167 - e172.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. Zhao, D. I. Lebovic, and R. N. Taylor
Long-Term Progestin Treatment Inhibits RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) Gene Expression in Human Endometrial Stromal Cells
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2514 - 2519.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
T. Bruland, H. Y. Dai, L. A. S. Lavik, L. I. Kristiansen, and A. Dalen
Gender-related differences in susceptibility, early virus dissemination and immunosuppression in mice infected with Friend murine leukaemia virus variant FIS-2
J. Gen. Virol., August 1, 2001; 82(8): 1821 - 1827.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
C. W. Roberts, W. Walker, and J. Alexander
Sex-Associated Hormones and Immunity to Protozoan Parasites
Clin. Microbiol. Rev., July 1, 2001; 14(3): 476 - 488.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
P. Portales, J. Clot, and P. Corbeau
Sex Differences in HIV-1 Viral Load Due to Sex Difference in CCR5 Expression
Ann Intern Med, January 2, 2001; 134(1): 81 - 82.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.